Recent Updates
Recently added Catalysts
XTNT Positive Sentiment

Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference

Monday, November 11, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Xtant Medical Holdings, Inc. announced that CEO Sean Browne and CFO Scott Neils will attend the 15th Annual Craig-Hallum Alpha Select Conference. This participation underscores the company's focus on engaging with stakeholders in the medical technology sector, particularly in spinal disorder solutions.
Price reaction · baseline $0.5255 (2024-11-08 close) · hit pre-market · 2 other XTNT headline(s) in the window, move may be shared
day 0 close · peak
-1.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Xtant Medical is actively participating in a prominent conference.
  • The attendance highlights the company's commitment to industry engagement.
  • CEO and CFO presence indicates strong leadership involvement.

Full Press Release Details

BELGRADE, MT / ACCESSWIRE / November 11, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced announced that Sean Browne , CEO and Scott Neils , CFO will be attending the

Frequently Asked Questions

Who will represent Xtant Medical at the conference?

CEO Sean Browne and CFO Scott Neils will represent Xtant Medical.

What is the focus of Xtant Medical?

Xtant Medical focuses on surgical solutions for spinal disorders.

What event will Xtant Medical attend?

Xtant Medical will attend the 15th Annual Craig-Hallum Alpha Select Conference.

When is the Craig-Hallum Alpha Select Conference?

The conference is scheduled for November 11, 2024.

ShareAdd on Google
Tags: XTNT Viatris Investor Conferences Healthcare Xtant Medical Craig-Hallum spinal disorders medical technology
Last updated: Nov 11, 2024

Biotech snapshot

Cash runway
$10M liquidity · $2M/mo burn
~4 mo
High dilution risk